文献速递糖尿病性腺与生殖内分泌

既往妊娠期糖尿病且合并糖尿病前期的女性以肠促胰素效应降低为特征

Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect.
PubMed 文献 · Diabetologia · 2017-03-31

横断面研究纳入102例既往妊娠期糖尿病(pGDM)无糖尿病女性与15例糖耐量正常(NGT)对照,行4小时75g OGTT及等血糖静脉葡萄糖输注,计算肠促胰素效应。pGDM中62%合并糖尿病前期,其肠促胰素效应为55.3%,低于NGT组73.8%与对照组76.7%(p<0.01)。

要点

  • pGDM女性中糖尿病前期患病率高,102例中63例(62%)为糖尿病前期。
  • 糖尿病前期组肠促胰素效应55.3%,低于NGT组73.8%与对照组76.7%(p<0.01)。
  • 糖尿病前期组Matsuda指数3.0,低于NGT组5.0与对照组1.5(p<0.001)。

核心结论

  • pGDM女性中糖尿病前期高度流行,且在发展为2型糖尿病之前即可检测到肠促胰素效应改变。

研究设计与样本

  • 横断面研究纳入102例无糖尿病的pGDM女性与15例无pGDM且糖耐量正常(NGT)的对照,均行4小时75g OGTT及等血糖静脉葡萄糖输注(IIGI)。
  • pGDM女性分为NGT或糖尿病前期(空腹血糖受损和/或糖耐量受损),胰岛素敏感性用Matsuda指数与HOMA2-IR评估,肠促胰素效应由胰岛素反应计算(100%×[AUC胰岛素,OGTT−AUC胰岛素,IIGI]/AUC胰岛素,OGTT)。

主要发现

  • 102例pGDM中63例(62%)为糖尿病前期(年龄中位数38.3岁,四分位距6.5;BMI 32.1 kg/m2,四分位距5.8),39例(38%)为NGT(年龄39.5岁,四分位距5.6;BMI 31.0 kg/m2,四分位距6.7)。
  • 对照15例与pGDM组在年龄(39.2岁,四分位距7.4)与BMI(28.8 kg/m2,四分位距9.2)上无显著差异。
  • Matsuda指数在糖尿病前期组为3.0(四分位距2.4),NGT组为5.0(四分位距2.6),对照组为1.5(四分位距1.8),p<0.001。
  • 肠促胰素效应在糖尿病前期组为55.3%(四分位距27.8),NGT组为73.8%(四分位距19.0),对照组为76.7%(四分位距24.6),p<0.01。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We investigated whether a reduced incretin effect, as observed in patients with type 2 diabetes, can be detected in high-risk individuals, such as women with prior gestational diabetes mellitus (pGDM). METHODS: In this cross-sectional study, 102 women without diabetes with pGDM and 15 control participants without pGDM and with normal glucose tolerance (NGT) underwent a 4 h 75 g OGTT and an isoglycaemic i.v. glucose infusion (IIGI). Women with pGDM were classified as having NGT or prediabetes (impaired fasting glucose and/or impaired glucose tolerance). Insulin sensitivity was assessed using the Matsuda index and HOMA2-IR and the incretin effect was calculated from insulin responses during the study (100% × [AUCinsulin,OGTT - AUCinsulin,IIGI]/AUCinsulin,OGTT). RESULTS: Sixty-three of the 102 women with pGDM (62%) had prediabetes (median [interquartile range]: age, 38.3 [6.5] years; BMI, 32.1 [5.8] kg/m2) and 39 women (38%) had NGT (age, 39.5 [5.6] years; BMI, 31.0 [6.7] kg/m2). Control participants (n = 15) were not significantly different from the pGDM group with regards to age (39.2 [7.4] years) and BMI (28.8 [9.2] kg/m2). Compared with women with NGT and control participants, women with prediabetes had lower insulin sensitivity, as measured by the Matsuda index (3.0 [2.4] vs 5.0 [2.6] vs 1.5 [1.8], respectively; p < 0.001). The incretin effect was 55.3% [27.8], 73.8% [19.0] and 76.7% [24.6] in women with prediabetes, women with normal glucose tolerance and control participants, respectively (p < 0.01). CONCLUSION/INTERPRETATION: Prediabetes was highly prevalent in women with pGDM, and alterations in the incretin effect were detected in this group before the development of type 2 diabetes. TRIAL REGISTRATION: clinicaltrialsregister.eu 2012-001371-37-DK.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Foghsgaard S, Vedtofte L, Andreasen C, et al. Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect. Diabetologia. 2017. PMID: 28364253. doi:10.1007/s00125-017-4265-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。